• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过心脏磁共振成像评估肺动脉高压时右心室容积和功能的临床重要变化。

Clinically important changes in right ventricular volume and function in pulmonary arterial hypertension assessed with cardiac magnetic resonance imaging.

作者信息

Göransson Christoffer, Vejlstrup Niels, Carlsen Jørn

机构信息

Department of Cardiology, Rigshospitalet Copenhagen University Hospital Copenhagen Denmark.

Department of Clinical Medicine, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark.

出版信息

Pulm Circ. 2022 Jul 1;12(3):e12097. doi: 10.1002/pul2.12097. eCollection 2022 Jul.

DOI:10.1002/pul2.12097
PMID:35833097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9262318/
Abstract

Right ventricular (RV) dilatation predicts clinical worsening in pulmonary arterial hypertension (PAH) and RV volumes can be measured with high precision using cardiovascular magnetic resonance imaging. In regular follow-up of patients and in studies of improvement in RV function, knowledge of clinically significant changes of RV volumes and function are of relevance. Patients with PAH were followed with cardiovascular magnetic resonance imaging and clinical assessment at 6-month intervals. Changes in RV volumes associated with changes in clinical status were assessed. Twenty-five patients with PAH (Group 1) were included and examined every 6 months for 2.5 years, with a total of 107 MRI scans. For a step change in WHO functional class, the associated change in RV volume was 11% (confidence interval 7%-14%,  < 0.0001) and in stroke volume 9% (confidence interval 3%-15%,  = 0.003). This study found an 11% change in RV volume to be clinically significant. The combination of clinically significant changes and the known precision in the measurements enables individualized follow-up of RV-function in PAH. To our knowledge, this study is the first to use repeated assessments to suggest clinically significant changes of RV volume based on changes in clinical presentation.

摘要

右心室(RV)扩张可预测肺动脉高压(PAH)患者的临床病情恶化,并且使用心血管磁共振成像能够高精度地测量RV容积。在对患者进行定期随访以及研究RV功能改善情况时,了解RV容积和功能具有临床意义的变化至关重要。对PAH患者每隔6个月进行一次心血管磁共振成像检查和临床评估,评估与临床状态变化相关的RV容积变化。纳入25例PAH患者(第1组),每6个月检查一次,共进行2.5年,总计107次MRI扫描。对于世界卫生组织功能分级的阶梯式变化,RV容积的相关变化为11%(置信区间7%-14%,P<0.0001),每搏输出量的相关变化为9%(置信区间3%-15%,P = 0.003)。本研究发现RV容积11%的变化具有临床意义。具有临床意义的变化与已知测量精度相结合,能够对PAH患者的RV功能进行个体化随访。据我们所知,本研究是首次利用重复评估根据临床表现变化提示RV容积具有临床意义的变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c23d/9262318/22297f28d029/PUL2-12-e12097-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c23d/9262318/74972ad94aa6/PUL2-12-e12097-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c23d/9262318/6f2570a7d69d/PUL2-12-e12097-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c23d/9262318/22297f28d029/PUL2-12-e12097-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c23d/9262318/74972ad94aa6/PUL2-12-e12097-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c23d/9262318/6f2570a7d69d/PUL2-12-e12097-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c23d/9262318/22297f28d029/PUL2-12-e12097-g003.jpg

相似文献

1
Clinically important changes in right ventricular volume and function in pulmonary arterial hypertension assessed with cardiac magnetic resonance imaging.通过心脏磁共振成像评估肺动脉高压时右心室容积和功能的临床重要变化。
Pulm Circ. 2022 Jul 1;12(3):e12097. doi: 10.1002/pul2.12097. eCollection 2022 Jul.
2
Establishing minimally important differences for cardiac MRI end-points in pulmonary arterial hypertension.确立肺动脉高压心脏 MRI 终点的最小有意义差异。
Eur Respir J. 2023 Aug 3;62(2). doi: 10.1183/13993003.02225-2022. Print 2023 Aug.
3
Cardiac-MRI Predicts Clinical Worsening and Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.心脏磁共振预测肺动脉高压临床恶化和死亡率:系统评价和荟萃分析。
JACC Cardiovasc Imaging. 2021 May;14(5):931-942. doi: 10.1016/j.jcmg.2020.08.013. Epub 2020 Sep 30.
4
Multi-Beat Right Ventricular-Arterial Coupling Predicts Clinical Worsening in Pulmonary Arterial Hypertension.多搏右心室-动脉偶联预测肺动脉高压的临床恶化。
J Am Heart Assoc. 2020 May 18;9(10):e016031. doi: 10.1161/JAHA.119.016031. Epub 2020 May 8.
5
Exercise cardiac MRI unmasks right ventricular dysfunction in acute hypoxia and chronic pulmonary arterial hypertension.运动心脏 MRI 揭示急性缺氧和慢性肺动脉高压中的右心室功能障碍。
Am J Physiol Heart Circ Physiol. 2018 Oct 1;315(4):H950-H957. doi: 10.1152/ajpheart.00146.2018. Epub 2018 May 18.
6
Implications of cardiac variability with cardiovascular magnetic resonance imaging for calculating trial sample size in pulmonary arterial hypertension.心血管磁共振成像中心律变异性对肺动脉高压临床试验样本量计算的影响。
Int J Cardiol. 2018 Apr 15;257:332-338. doi: 10.1016/j.ijcard.2017.11.020.
7
The REPAIR Study: Effects of Macitentan on RV Structure and Function in Pulmonary Arterial Hypertension.REPAIR研究:马昔腾坦对肺动脉高压患者右心室结构和功能的影响
JACC Cardiovasc Imaging. 2022 Feb;15(2):240-253. doi: 10.1016/j.jcmg.2021.07.027. Epub 2021 Nov 17.
8
Three-dimensional modeling of the right ventricle from two-dimensional transthoracic echocardiographic images: utility of knowledge-based reconstruction in pulmonary arterial hypertension.从二维经胸超声心动图图像对右心室进行三维建模:知识重建在肺动脉高压中的应用。
J Am Soc Echocardiogr. 2013 Aug;26(8):860-7. doi: 10.1016/j.echo.2013.05.007. Epub 2013 Jun 13.
9
Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.射血分数保留的心力衰竭合并肺动脉高压患者的右心室弥漫性纤维化。
ESC Heart Fail. 2020 Feb;7(1):253-263. doi: 10.1002/ehf2.12565. Epub 2020 Jan 5.
10
Magnetic resonance imaging of the right ventricle in pediatric pulmonary arterial hypertension.右心室磁共振成像在儿科肺动脉高压中的应用。
Pulm Circ. 2013 Apr;3(2):350-5. doi: 10.4103/2045-8932.114763.

引用本文的文献

1
Deep Learning-Based CT-Less Cardiac Segmentation of PET Images: A Robust Methodology for Multi-Tracer Nuclear Cardiovascular Imaging.基于深度学习的PET图像无CT心脏分割:一种用于多示踪剂核心血管成像的稳健方法。
J Imaging Inform Med. 2025 May 6. doi: 10.1007/s10278-025-01528-0.
2
Comparison of cardiac magnetic resonance imaging, functional and haemodynamic variables in pulmonary arterial hypertension: insights from REPAIR.肺动脉高压中心脏磁共振成像、功能及血流动力学变量的比较:来自REPAIR研究的见解
ERJ Open Res. 2024 Feb 12;10(1). doi: 10.1183/23120541.00547-2023. eCollection 2024 Jan.
3
CS1, a controlled-release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trial.

本文引用的文献

1
The REPAIR Study: Effects of Macitentan on RV Structure and Function in Pulmonary Arterial Hypertension.REPAIR研究:马昔腾坦对肺动脉高压患者右心室结构和功能的影响
JACC Cardiovasc Imaging. 2022 Feb;15(2):240-253. doi: 10.1016/j.jcmg.2021.07.027. Epub 2021 Nov 17.
2
The Value of Hemodynamic Measurements or Cardiac MRI in the Follow-up of Patients With Idiopathic Pulmonary Arterial Hypertension.特发性肺动脉高压患者随访中心血管磁共振血流动力学测量的价值。
Chest. 2021 Apr;159(4):1575-1585. doi: 10.1016/j.chest.2020.10.077. Epub 2020 Nov 14.
3
Cardiac-MRI Predicts Clinical Worsening and Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.
丙戊酸控释制剂CS1用于治疗肺动脉高压患者:一项2期临床试验的原理与设计
Pulm Circ. 2024 Jan 3;14(1):e12323. doi: 10.1002/pul2.12323. eCollection 2024 Jan.
4
Establishing minimally important differences for cardiac MRI end-points in pulmonary arterial hypertension.确立肺动脉高压心脏 MRI 终点的最小有意义差异。
Eur Respir J. 2023 Aug 3;62(2). doi: 10.1183/13993003.02225-2022. Print 2023 Aug.
心脏磁共振预测肺动脉高压临床恶化和死亡率:系统评价和荟萃分析。
JACC Cardiovasc Imaging. 2021 May;14(5):931-942. doi: 10.1016/j.jcmg.2020.08.013. Epub 2020 Sep 30.
4
BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?在肺动脉高压中应用 BNP/NT-proBNP:即时检测的时机是否已到?
Eur Respir Rev. 2020 May 15;29(156). doi: 10.1183/16000617.0009-2020. Print 2020 Jun 30.
5
Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension.肺动脉高压危险分层的心脏磁共振成像阈值的确定。
Am J Respir Crit Care Med. 2020 Feb 15;201(4):458-468. doi: 10.1164/rccm.201909-1771OC.
6
The right treatment for the right ventricle.右心室的正确治疗方法。
Curr Opin Pulm Med. 2019 Sep;25(5):410-417. doi: 10.1097/MCP.0000000000000610.
7
Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update.肺动脉高压中心脏右心室和肺循环的病理生理学:更新。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01900-2018. Print 2019 Jan.
8
Risk stratification and medical therapy of pulmonary arterial hypertension.肺动脉高压的风险分层与药物治疗。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01889-2018. Print 2019 Jan.
9
Implications of cardiac variability with cardiovascular magnetic resonance imaging for calculating trial sample size in pulmonary arterial hypertension.心血管磁共振成像中心律变异性对肺动脉高压临床试验样本量计算的影响。
Int J Cardiol. 2018 Apr 15;257:332-338. doi: 10.1016/j.ijcard.2017.11.020.
10
Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry.基线和连续脑利钠肽水平可预测肺动脉高压患者 5 年总生存率:来自 REVEAL 登记的数据。
Chest. 2018 Jul;154(1):126-135. doi: 10.1016/j.chest.2018.01.009. Epub 2018 Jan 31.